-
Johnson & Johnson submits FDA application for Caplyta to prevent schizophrenia relapse
Source: Pharmafile Published on 2025-07-18
-
EMA lifts temporary ban on chikungunya vaccine Ixchiq following safety review
Source: Pharmafile Published on 2025-07-18
-
Biogen and Stoke report positive results for Dravet syndrome drug
Source: Pharmafile Published on 2025-07-17
-
Addenbrooke’s hospital offers first self-service digital eye test
Source: Pharmafile Published on 2025-07-17
-
Jazz Pharmaceuticals appoints Renée Galá as CEO to lead next phase of growth
Source: Pharmafile Published on 2025-07-16
-
FDA approves Moderna’s Spikevax for children at increased risk of COVID-19
Source: Pharmafile Published on 2025-07-16
-
Pharvaris to report phase 3 data and submit New Drug Application
Source: Pharmafile Published on 2025-07-15
-
Osivax publishes positive results from trial of influenza vaccine candidate
Source: Pharmafile Published on 2025-07-15
-
VIVES Partners contributes to €84m funding for radiopharma company, Nuclidium
Source: Pharmafile Published on 2025-07-14
-
Secarna and Vect-Horus collaborate to advance therapies for central nervous system disorders
Source: Pharmafile Published on 2025-07-14
-
Cube Biotech appoints Joachim Kreuzburg to its board of directors
Source: Pharmafile Published on 2025-07-11
-
NICE recommends NHS use of mirikizumab for Crohn’s disease
Source: Pharmafile Published on 2025-07-11
-
BioMed X and Servier launch Europe’s first XSeed Labs to advance AI-powered antibody design
Source: Pharmafile Published on 2025-07-11
-
Norstella appoints Kris Joshi as CEO to drive next phase of growth
Source: Pharmafile Published on 2025-07-10
-
Amarna Therapeutics and NorthX Biologics collaborate to advance gene therapy for type 1 diabetes
Source: Pharmafile Published on 2025-07-10